Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit

Rhea-AI Summary

Jupiter Neurosciences (NASDAQ: JUNS) will present at the Market Movers Investor Summit on Tuesday, May 5, 2026 at 9:00 AM ET at 48 Wall Street (the original Bank of New York). Christer Rosén, chairman and CEO, will deliver the company presentation.

The summit runs May 4–5, 2026, and features company presentations, fireside chats, one-on-one meetings, and networking for public and private company executives, fund managers, and family offices. Invitation requests available via the summit website.

News Market Reaction – JUNS

+3.33% 1.5x vol

6 alerts

+3.33% Session close to close

+16.2% Peak Tracked

-2.4% Trough Tracked

$15.13M Market Cap

1.5x Rel. Volume

In the May 4 session, JUNS gained 3.33%, reflecting a moderate positive market reaction. Argus tracked a peak move of +16.2% during that session. Argus tracked a trough of -2.4% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. Trading volume was above average at 1.5x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement adds another investor-relations touchpoint, with Jupiter Neurosciences presenting ...

Analysis

This announcement adds another investor-relations touchpoint, with Jupiter Neurosciences presenting JOTROL™ at a high-access summit on May 5, 2026 in New York. It follows several recent conferences and investor events focused on the company’s clinical and commercial story. Investors may watch how ongoing presentations intersect with the newly effective $100,000,000 shelf registration, recent Nasdaq compliance notices, and progress in the Phase IIa Parkinson’s program discussed in prior filings.

Key Figures

Summit date: May 5, 2026 Presentation time: 09:00 AM ET Summit location: 48 Wall Street +1 more

4 metrics

Summit date May 5, 2026 Company presentation date at Market Movers Investor Summit

Presentation time 09:00 AM ET Scheduled start time for JUNS presentation

Summit location 48 Wall Street Venue address (The original Bank of New York)

Summit kickoff date May 4, 2026 Kickoff party at Delmonico’s before full programming day

Historical Context

5 past events · Latest: Apr 13 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 13	Investor conference	Positive	-1.4%	Centri Capital Conference presentation and investor meetings in New York.
Apr 07	Advisory board change	Positive	+2.6%	New Nugevia advisory board members with distribution expertise added.
Mar 31	Investor conference	Positive	+15.8%	Emerging Growth Conference presentation on JOTROL clinical and commercial progress.
Mar 02	Investor summit	Positive	-4.4%	BIO Investment and Growth Summit talk on IND clearance and Parkinson’s program.
Feb 25	Investor event	Positive	+0.9%	Exclusive investor dinner presentation on clinical and commercial progress.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has focused on conferences and investor events, with mixed price reactions: some presentations led to gains while others saw selling, indicating inconsistent trading responses to similar investor-relations catalysts.

Recent Company History

Over the last few months, Jupiter Neurosciences has repeatedly highlighted its JOTROL™ platform and Parkinson’s Phase IIa program across multiple investor venues. Events include presentations at the BIO Investment and Growth Summit on Mar 2, 2026, Emerging Growth Conference on Mar 31, 2026, and the Centri Capital Conference on Apr 13, 2026, plus a Mar-a-Lago investor dinner. The current Market Movers Investor Summit appearance continues this pattern of active investor outreach and conference participation.

Key Terms

clinical-stage, resveratrol-based

2 terms

clinical-stage medical

"a clinical-stage pharmaceutical company developing JOTROL™"

Clinical-stage describes a drug, therapy, or company whose product is being tested in human trials but has not yet received regulatory approval. For investors, it signals that the project has moved beyond lab work into real-world testing—meaning higher potential reward if trials succeed but also clear risks from trial setbacks, costs, and regulatory delay; think of it like a prototype car on public road tests that could either prove its value or reveal problems that stop it from reaching production.

resveratrol-based medical

"developing JOTROL™, a patented resveratrol-based platform"

Products, treatments, or formulations that use resveratrol—a naturally occurring compound found in certain plants—as a primary active ingredient or key selling feature. For investors, “resveratrol-based” signals a focus on antioxidant, anti-inflammatory, or longevity claims that can affect market demand, regulatory review, and clinical evidence requirements; think of it as a product built around a single headline ingredient, like a car marketed mainly for its electric motor. The term does not guarantee effectiveness or regulatory approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Jupiter, Florida--(Newsfile Corp. - May 4, 2026) - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, announced today that it will be participating in the Market Movers Investor Summit on Tuesday May 5, 2026. The presentation will take place at 09:00 AM ET at the historic Bank of New York. Christer Rosén, Chairman and CEO, will be giving the presentation.

The Market Movers Investor Summit is a premier, high-access event on Wall Street. The Inaugural program features fireside chats with Alex Rodriguez, Chairman and CEO of A-Rod Corp, and Grant Cardone, CEO of Cardone Capital, in addition to company presentations and one-on-one meetings throughout the day.

Event Details:

• Summit Dates: May 5, 2026
• Company Presentation: Tuesday, May 5, 2026
• Time: 09:00 AM ET
• Location: 48 Wall Street, New York, NY (The original Bank of New York)

Request an invitation to attend at www.marketmoverssummit.com.

Summary of Market Movers Investor Summit

The 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico’s, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen and a surprise musical guest.

About Jupiter Neurosciences, Inc.

Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia™ product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated improved bioavailability in clinical studies. The Company's prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson's disease, including indications such as Alzheimer's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS.

About Market Movers

Market Movers is a next-generation investor conference designed for people responsible for capital, growth, and strategic outcomes. Hosted on Wall Street inside the original Bank of New York, the event brings together public & company leaders, investors, real estate principals, founders, and operators for a focused, high-access experience. The emphasis is on meaningful conversations, real connections, and perspectives that extend beyond a single market or asset class.

To learn more about the Market Movers Investor Summit, visit:
https://www.marketmoverssummit.com

For further information on Jupiter Neurosciences, Inc.
Christer Rosén
(561) 406-6154
ir@jupiterneurosciences.com
https://jupiterneurosciences.com

FAQ

When and where will Jupiter Neurosciences (JUNS) present at the Market Movers Investor Summit?

Jupiter Neurosciences will present on Tuesday, May 5, 2026 at 9:00 AM ET. According to Jupiter Neurosciences, the presentation is scheduled at 48 Wall Street in New York City, the original Bank of New York, during the summit's main programming day.

Who from Jupiter Neurosciences will speak at the JUNS presentation on May 5, 2026?

Christer Rosén, chairman and CEO, will give the presentation. According to Jupiter Neurosciences, Rosén will represent the company during its scheduled company presentation and may participate in investor Q&A and one-on-one meetings throughout the summit day.

What is the Market Movers Investor Summit agenda relevant to JUNS investors on May 5, 2026?

The agenda includes company presentations, fireside chats, and one-on-one investor meetings. According to Jupiter Neurosciences, the May 5 schedule offers access to executives, fund managers, and family offices and features keynote sessions and networking opportunities.

How can investors request an invitation to attend the JUNS presentation at the Market Movers Summit?

Investors can request an invitation via the Market Movers Summit website. According to Jupiter Neurosciences, invitations and registration details are available at www.marketmoverssummit.com for the May 4–5, 2026 event.

Will Jupiter Neurosciences discuss clinical-stage development or JOTROL at the Market Movers Summit (JUNS)?

The company will present at the summit; specific presentation topics are not listed in the announcement. According to Jupiter Neurosciences, Christer Rosén will present on May 5, but topic details such as JOTROL clinical updates were not specified in the event notice.